Hawkins Richard J

Director at SCICLONE PHARMACEUTICALS INC · on record since Jun 15, 2006
Director at CYTORI THERAPEUTICS, INC. · on record since Dec 21, 2007
Director at ADVENTRX PHARMACEUTICALS INC · on record since May 5, 2017
Director at NEWLINK GENETICS CORP · on record since Mar 30, 2020
Chief Executive Officer at NEWLINK GENETICS CORP · on record since Mar 30, 2020

Insider trading activity of Hawkins Richard J

Transactions on record: 151; since Nov 2, 2004

Open-market buys: 9; $163.1K

Open-market sells: 14; $2.1M

Companies traded: 4; last filing Jul 1, 2026

Figures computed from official regulatory filings — methodology.

Companies where Hawkins Richard J has traded

CYTORI THERAPEUTICS, INC.44 tx · $25.5K · Jul 1, 2026
ADVENTRX PHARMACEUTICALS INC29 tx · $434.2K · Dec 11, 2025
NEWLINK GENETICS CORP29 tx · $159.8K · Dec 13, 2024
SCICLONE PHARMACEUTICALS INC49 tx · $3.5M · Oct 16, 2017

Track record of Hawkins Richard J

Statistical track record

Free

Open-market buys: 9

Last buy: Jun 20, 2025

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of Hawkins Richard J

Co-insiders of Hawkins Richard J

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
CYTORI THERAPEUTICS, INC.	Jul 1, 2026	ExerciseD	-922	0.00 USD	—	SEC
CYTORI THERAPEUTICS, INC.	Jul 1, 2026	Exercise	922	0.00 USD	—	SEC
CYTORI THERAPEUTICS, INC.	May 18, 2026	AwardD	3,686	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	May 18, 2026	AwardD	3,686	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Dec 11, 2025	Award	40,000	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Nov 17, 2025	Exercise	5,860	1.46 USD	$8.6K	SEC
ADVENTRX PHARMACEUTICALS INC	Nov 17, 2025	ExerciseD	-5,860	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Aug 15, 2025	AwardD	397,794	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Jun 23, 2025	Buy	48,225	2.04 USD	$98.4K	SEC
CYTORI THERAPEUTICS, INC.	Feb 20, 2025	AwardD	40,122	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Dec 16, 2024	Sell	-8,000	3.32 USD	$26.6K	SEC
ADVENTRX PHARMACEUTICALS INC	Dec 16, 2024	Award	40,000	0.00 USD	$0	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-35,400	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-19,624	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-35,400	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-135,000	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	Other	-753,093	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-28,475	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	Other	-4,469	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-35,400	—	—	SEC
CYTORI THERAPEUTICS, INC.	Sep 17, 2024	Buy	4,000	1.50 USD	$6K	SEC
CYTORI THERAPEUTICS, INC.	Sep 16, 2024	Buy	6,285	1.35 USD	$8.5K	SEC
CYTORI THERAPEUTICS, INC.	Sep 12, 2024	AwardD	3,650	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	May 10, 2024	AwardD	9,804	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	May 10, 2024	Buy	4,902	2.04 USD	$10K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
CYTORI THERAPEUTICS, INC.	Jul 1, 2026	ExerciseD	-922	0.00 USD	—	SEC
CYTORI THERAPEUTICS, INC.	Jul 1, 2026	Exercise	922	0.00 USD	—	SEC
CYTORI THERAPEUTICS, INC.	May 18, 2026	AwardD	3,686	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	May 18, 2026	AwardD	3,686	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Dec 11, 2025	Award	40,000	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Nov 17, 2025	Exercise	5,860	1.46 USD	$8.6K	SEC
ADVENTRX PHARMACEUTICALS INC	Nov 17, 2025	ExerciseD	-5,860	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	Aug 15, 2025	AwardD	397,794	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Jun 23, 2025	Buy	48,225	2.04 USD	$98.4K	SEC
CYTORI THERAPEUTICS, INC.	Feb 20, 2025	AwardD	40,122	0.00 USD	$0	SEC
ADVENTRX PHARMACEUTICALS INC	Dec 16, 2024	Sell	-8,000	3.32 USD	$26.6K	SEC
ADVENTRX PHARMACEUTICALS INC	Dec 16, 2024	Award	40,000	0.00 USD	$0	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-35,400	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-19,624	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-35,400	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-135,000	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	Other	-753,093	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-28,475	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	Other	-4,469	—	—	SEC
NEWLINK GENETICS CORP	Dec 13, 2024	OtherD	-35,400	—	—	SEC
CYTORI THERAPEUTICS, INC.	Sep 17, 2024	Buy	4,000	1.50 USD	$6K	SEC
CYTORI THERAPEUTICS, INC.	Sep 16, 2024	Buy	6,285	1.35 USD	$8.5K	SEC
CYTORI THERAPEUTICS, INC.	Sep 12, 2024	AwardD	3,650	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	May 10, 2024	AwardD	9,804	0.00 USD	$0	SEC
CYTORI THERAPEUTICS, INC.	May 10, 2024	Buy	4,902	2.04 USD	$10K	SEC